Hemopurifier, a blood filtration device, is showing promising early results in oncology trials by reducing harmful particles and supporting immune function. The company is well-financed, focused on completing its current trial, and aims to expand its platform to multiple disease areas.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.